Diemert D, Zumer M, Bova M, Gibbs-Tewary C, Malkin E, Campbell D
PLoS Negl Trop Dis. 2025; 18(12):e0012788.
PMID: 39775205
PMC: 11717351.
DOI: 10.1371/journal.pntd.0012788.
Portilho A, Silva V, Hermes Monteiro da Costa H, Yamashiro R, de Oliveira I, de Campos I
Sci Rep. 2024; 14(1):20003.
PMID: 39198569
PMC: 11358332.
DOI: 10.1038/s41598-024-71047-5.
Mohamed Bahgat M, Hassan Nasraa M, Nadeem R, Amer K, Hassan W, Abd El-Raouf A
J Genet Eng Biotechnol. 2024; 22(3):100399.
PMID: 39179319
PMC: 11345650.
DOI: 10.1016/j.jgeb.2024.100399.
Zhang T, Liu H, Tian M, Zhou M, Zhou H, Zhang X
Clin Rheumatol. 2024; 43(8):2595-2606.
PMID: 38907850
DOI: 10.1007/s10067-024-07033-z.
Zhang P, Wu Q, Xu X, Chen M
Front Immunol. 2024; 15:1303589.
PMID: 38455056
PMC: 10917890.
DOI: 10.3389/fimmu.2024.1303589.
Appearance of tolerance-induction and non-inflammatory SARS-CoV-2 spike-specific IgG4 antibodies after COVID-19 booster vaccinations.
Akhtar M, Islam M, Khaton F, Soltana U, Jafrin S, Rahman S
Front Immunol. 2024; 14:1309997.
PMID: 38173725
PMC: 10763240.
DOI: 10.3389/fimmu.2023.1309997.
B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity.
Lapuente D, Winkler T, Tenbusch M
Cell Mol Immunol. 2023; 21(2):144-158.
PMID: 37945737
PMC: 10805925.
DOI: 10.1038/s41423-023-01095-w.
Non-neutralizing functions in anti-SARS-CoV-2 IgG antibodies.
Reinig S, Shih S
Biomed J. 2023; 47(1):100666.
PMID: 37778697
PMC: 10825350.
DOI: 10.1016/j.bj.2023.100666.
Does SARS-CoV-2 Induce IgG4 Synthesis to Evade the Immune System?.
Rubio-Casillas A, Redwan E, Uversky V
Biomolecules. 2023; 13(9).
PMID: 37759738
PMC: 10526126.
DOI: 10.3390/biom13091338.
Antibody-Dependent Enhancement with a Focus on SARS-CoV-2 and Anti-Glycan Antibodies.
Ziganshina M, Shilova N, Khalturina E, Dolgushina N, V Borisevich S, Yarotskaya E
Viruses. 2023; 15(7).
PMID: 37515270
PMC: 10384250.
DOI: 10.3390/v15071584.
Combined REGN-COV2 Antibody Therapy Immediately Prevented a Patient with Refractory Type 1 Autoimmune Pancreatitis from Contracting SARS-CoV-2 during the Sixth Wave in Japan.
Katsuo C, Kubota K, Tanaka K, Kurita Y, Nakajima A
Intern Med. 2023; 62(12):1765-1770.
PMID: 37316279
PMC: 10332964.
DOI: 10.2169/internalmedicine.1421-22.
Multifaceted roles of Fcγ receptors in COVID-19 and vaccine responses.
Bouayad A
Am J Transl Res. 2023; 15(5):3040-3059.
PMID: 37303668
PMC: 10250970.
IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein.
Uversky V, Redwan E, Makis W, Rubio-Casillas A
Vaccines (Basel). 2023; 11(5).
PMID: 37243095
PMC: 10222767.
DOI: 10.3390/vaccines11050991.
Decreased breadth of the antibody response to the spike protein of SARS-CoV-2 after repeated vaccination.
Horndler L, Delgado P, Romero-Pinedo S, Quesada M, Balabanov I, Laguna-Goya R
Front Immunol. 2023; 14:1157263.
PMID: 37081876
PMC: 10111966.
DOI: 10.3389/fimmu.2023.1157263.
Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases, in Patients with Cardiac Issues, and in the Healthy Population.
Frasca L, Ocone G, Palazzo R
Pathogens. 2023; 12(2).
PMID: 36839505
PMC: 9964607.
DOI: 10.3390/pathogens12020233.
The clinical significance of allergen-specific IgG4 in allergic diseases.
Qin L, Tang L, Cheng L, Wang H
Front Immunol. 2022; 13:1032909.
PMID: 36389804
PMC: 9648126.
DOI: 10.3389/fimmu.2022.1032909.
Evaluation of Free Light Chains (FLCs) Synthesis in Response to Exposure to SARS-CoV-2.
Gudowska-Sawczuk M, Moniuszko-Malinowska A, Paczek S, Guziejko K, Chorazy M, Mroczko B
Int J Mol Sci. 2022; 23(19).
PMID: 36232891
PMC: 9569841.
DOI: 10.3390/ijms231911589.
May IgG4-related disease be reactivated by SARS-CoV-2 infection?.
Kobak S
Reumatologia. 2022; 60(2):161-162.
PMID: 35782033
PMC: 9238317.
DOI: 10.5114/reum.2022.115985.
Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: a European multi-centre study.
Ramirez G, Lanzillotta M, Ebbo M, Fernandez-Codina A, Mancuso G, Orozco-Galvez O
Rheumatology (Oxford). 2021; 61(5):e109-e111.
PMID: 34919665
PMC: 9383139.
DOI: 10.1093/rheumatology/keab930.